Invention Grant
- Patent Title: Anti-ADAM28 antibody for treating cancer
-
Application No.: US15815148Application Date: 2017-11-16
-
Publication No.: US10556967B2Publication Date: 2020-02-11
- Inventor: Akira Miyakoshi , Rena Matsumoto , Shizue Katoh , Yuki Hayami , Satsuki Mochizuki , Masayuki Shimoda , Yasunori Okada
- Applicant: GENEFRONTIER CORPORATION , KEIO UNIVERSITY
- Applicant Address: JP Kashiwa JP Tokyo
- Assignee: GENEFRONTIER CORPORATION,KEIO UNIVERSITY
- Current Assignee: GENEFRONTIER CORPORATION,KEIO UNIVERSITY
- Current Assignee Address: JP Kashiwa JP Tokyo
- Agency: Leydig, Voit & Mayer, Ltd.
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/00 ; C07K16/40 ; C07K16/28 ; A61K39/00
Abstract:
The present invention provides an antibody that specifically binds to human ADAM28, inhibits enzyme activity of human ADAM28, and has an activity to suppress metastasis of a cancer cell that expresses human ADAM28. The antibody of the present invention can be a human antibody.
Public/Granted literature
- US20180155448A1 ANTI-ADAM28 ANTIBODY FOR TREATING CANCER Public/Granted day:2018-06-07
Information query
